You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

20-201

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atopic Dermatitis Trial in China (CBP-201)

Not yet recruiting
  • Atopic Dermatitis
  • Beijing, Beijing, China
  • +40 more
Jun 14, 2023

Pharmacokinetics Trial in Miami (Progesterone vaginal ring,)

Completed
  • Pharmacokinetics
  • Progesterone vaginal ring,
  • Miami, Florida
    Teva Investigational Site 12355
Nov 6, 2021

Glabellar Lines Trial in Canada, Germany, United States (IncobotulinumtoxinA (Xeomin) (20 units))

Completed
Has Results
  • Glabellar Lines
  • IncobotulinumtoxinA (Xeomin) (20 units)
  • Los Angeles, California
  • +24 more
Mar 8, 2021

Moderate-to-severe Atopic Dermatitis Trial in China (CBP-201, Placebo)

Recruiting
  • Moderate-to-severe Atopic Dermatitis
  • Hefei, Anhui, China
  • +55 more
Sep 22, 2021

Solid Tumors Trial in Singapore, United States (ETC-1922159, Pembrolizumab)

Recruiting
  • Solid Tumors
  • Tucson, Arizona
  • +10 more
Sep 16, 2022

Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury Trial in Worldwide (NT 201,

Recruiting
  • Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury
  • NT 201
  • Placebo
  • Stamford, Connecticut
  • +53 more
Aug 19, 2022

Cerebral Palsy, Spasticity Trial in Worldwide (IncobotulinumtoxinA (8 Units per kg body weight), IncobotulinumtoxinA (6 Units

Completed
Has Results
  • Cerebral Palsy
  • Spasticity
  • IncobotulinumtoxinA (8 Units per kg body weight)
  • +2 more
  • Gulf Breeze, Florida
  • +31 more
Aug 3, 2021

Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury

Not yet recruiting
  • Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury
  • IncobotulinumtoxinA
  • Placebo
  • (no location specified)
Oct 13, 2023

Solid Tumor, Adult Trial in Worldwide (ASTX029)

Recruiting
  • Solid Tumor, Adult
  • Duarte, California
  • +26 more
Nov 18, 2022

Squamous-Cell Non-Small-Cell Lung Cancer Trial in Worldwide (Bemarituzumab, Docetaxel)

Recruiting
  • Squamous-Cell Non-Small-Cell Lung Cancer
  • Orange, California
  • +24 more
Jul 27, 2022

Prostatic Tumors Trial in Worldwide (BAY1841788 / darolutamide (ODM-201), Standard ADT (androgen deprivation therapy),

Active, not recruiting
  • Metastatic Hormone-sensitive Prostate Cancer
  • BAY1841788 / darolutamide (ODM-201)
  • +3 more
  • Chandler, Arizona
  • +298 more
Sep 28, 2022

Lower Limb Spasticity Due to Cerebral Palsy Trial in Worldwide (IncobotulinumtoxinA (16 Units per kg body weight),

Completed
Has Results
  • Lower Limb Spasticity Due to Cerebral Palsy
  • IncobotulinumtoxinA (16 Units per kg body weight)
  • +2 more
  • Graz, Austria
  • +52 more
Aug 3, 2021

Systemic Lupus Erythematosus Trial in Worldwide (Lupuzor)

Terminated
Has Results
  • Systemic Lupus Erythematosus
  • Birmingham, Alabama
  • +84 more
Dec 5, 2022

Acute Myeloid Leukemia, MDS Trial in Omaha (ONC201)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Omaha, Nebraska
    University of Nebraska Medical Center
Aug 4, 2022

Lymphoma, Non-Hodgkin Trial in Worldwide (Fludarabine, Cyclophosphamide, JCAR017)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Santa Monica, California
  • +36 more
Jan 25, 2023

Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Trial in

Completed
  • Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
  • PDR001
  • +5 more
  • Santa Monica, California
  • +24 more
Mar 11, 2022

Allergy Trial in Worldwide (SQ tree SLIT-tablet, Placebo)

Recruiting
  • Allergy
  • SQ tree SLIT-tablet
  • Placebo
  • Vienna, Austria
  • +83 more
Dec 21, 2022

Light Chain (AL) Amyloidosis Trial in Sacramento (NXC-201 CAR-T)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • NXC-201 CAR-T
  • Sacramento, California
    University of California Davis Medical Center
Oct 19, 2023

MDS Trial in Worldwide (MBG453, Placebo, Hypomethylating agents)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Duarte, California
  • +46 more
Jan 20, 2023

Pulmonary Arterial Hypertension Trial in Worldwide (Oral zamicastat)

Completed
  • Pulmonary Arterial Hypertension
  • Oral zamicastat
  • Linz, Austria
  • +10 more
Aug 18, 2023

Uveal Melanoma, Metastatic Trial in Tampa (4.7 microCi 225Ac-MTI-201, 9.5 microCi of 225Ac-MTI-201, 19 microCi of 225Ac-MTI-201)

Recruiting
  • Uveal Melanoma
  • Metastatic
  • 4.7 microCi 225Ac-MTI-201
  • +11 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 9, 2022

Tumors Trial in Worldwide (CC-95251, Rituximab, Cetuximab)

Recruiting
  • Neoplasms
  • Birmingham, Alabama
  • +62 more
Jan 19, 2023

Jansky-Bielschowsky Disease, Batten Disease, Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 Trial in Worldwide (BMN 190,

Completed
Has Results
  • Jansky-Bielschowsky Disease
  • +4 more
  • BMN 190
  • Intracerebroventricular (ICV) access device
  • Columbus, Ohio
  • +3 more
Jul 28, 2022

Prurigo Nodularis Trial in Worldwide (Nalbuphine ER Tablets, Matching Placebo Tablets)

Active, not recruiting
  • Prurigo Nodularis
  • Nalbuphine ER Tablets
  • Matching Placebo Tablets
  • Phoenix, Arizona
  • +69 more
Jan 31, 2023

Allergy Trial in Worldwide (5-grass mix SLIT-drops, Placebo)

Active, not recruiting
  • Allergy
  • 5-grass mix SLIT-drops
  • Placebo
  • Brno, Czechia
  • +47 more
Aug 12, 2022